European Journal of Cancer
Volume 38, Issue 10 , Pages 1380-1387 , July 2002

An evaluation of chest X-ray screening for lung cancer in gunma prefecture, Japan: a population-based case–control study

  • T Nakayama

      Affiliations

    • Division of Epidemiology, Department of Field Research, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3 Nakamichi 1-chome, Higashinari-ku, Osaka 537-8511, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-6-6972-7561; fax: +81-6-6972-7581
    • ,
  • T Baba

      Affiliations

    • The Gunma Health Foundation, Maebashi, Japan
    • ,
  • T Suzuki

      Affiliations

    • Division of Epidemiology, Department of Field Research, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3 Nakamichi 1-chome, Higashinari-ku, Osaka 537-8511, Japan
    • ,
  • M Sagawa

      Affiliations

    • Department of Thoracic Surgery, Kanazawa Medical University, Ishikawa, Japan
    • ,
  • M Kaneko

      Affiliations

    • Division of Endoscopy, National Cancer Center Hospital, Tokyo, Japan

Received 31 May 2001 ,Revised 13 November 2001 ,Accepted 12 January 2002.

References 

  1. Fontana RS, Sanderson DR, Woolner LB, et al.  Screening for lung cancer (a critique of the Mayo Lung Project). Cancer. 1991;67:1155–1164
  2. Melamed MR, Flehinger BJ, Zaman MB, et al.  Screening for early lung cancer (results of the Memorial Sloan-Kettering study in New York). Chest. 1994;86:44–53
  3. Tockman MS, Levin ML, Frost JK, et al.  Screening and detection of lung cancer. In:  Aisner J editors. Lung Cancer. New York: Churchill and Livingstone; 1985;p. 25–40
  4. Myers MH, Glocekler Ries LA. Cancer patient survival rates (SEER programme results for 10 years of followup). CA Cancer J. Clin. 1989;39:21–39
  5. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al.  Lung cancer mortality in the Mayo Lung Project (impact of extended follow-up). J. Natl. Cancer Inst. 2000;92:1308–1316
  6. Sobue T, Nakayama T. Re: lung cancer mortality in the Mayo Lung Project (impact of extended follow-up). J. Natl. Cancer Inst. 2001;93:320–321
  7. Sobue T, Suzuki T, Naruke T  The Japanese Lung-Cancer-Screening Research Group . A case-control study for evaluating lung-cancer screening in Japan. Int. J. Cancer. 1992;50:230–237
  8. Okamoto N, Suzuki T, Hasegawa H, et al.  Evaluation of a clinic-based screening programme for lung cancer with a case-control design in Kanagawa, Japan. Lung Cancer. 1999;25:77–85
  9. US Preventive Service Task Force. Guide to Clinical Preventive Services, 2nd ed. Baltimore, Williams & Wilkins, 1996, 39–55.
  10. Weiss NS. Application of the case-control method in the evaluation of screening. Epidemiol. Rev. 1994;16:102–108
  11. Morrison AS. Case definition in case-control studies of the efficacy of screening. Am. J. Epidemiol. 1982;115:6–8
  12. Breslow NE, Day NE. The analysis of case-control studies. In:  Davis W editors. Statistical Methods in Cancer Research 32. Lyon: IARC Scientific Publications; 1980;p. 162–189
  13. Soda H, Tomita H, Kohno S, Oka M. Limitation of annual screening chest radiography for the diagnosis of lung cancer. A retrospective study. Cancer. 1993;72:2341–2346
  14. Flehinger BJ, Kimmel M, Melamed MR. Natural history of adenocarcinoma—large cell carcinoma of the lung (conclusions from screening programmes in New York and Baltimore). Cancer. 1988;80:337–344
  15. Hanai A, Benn T, Fujimoto I, Muir CS. Comparison of lung cancer incidence rates by histologic type in high and low incidence countries, with special reference to the limited role of smoking. Jpn. J. Cancer Res. (Gann). 1988;79:445–452
  16. Tominaga S. Cancer prevention by stopping smoking. Gan To Kagaku Ryoho. 1998;25:789–796
  17. Weiss NS, Lazovich D. Case-control studies of screening efficacy (the use of persons newly diagnosed with cancer who later sustain an unfavorable outcome). Am. J. Epidemiol. 1996;143:319–322
  18. Pisani P, Oliver WE, Parkin DM, Alvarez N, Vivas J. Case-control study of gastric cancer screening in Venezuela. Br. J. Cancer. 1994;69:1102–1105
  19. Weiss NS. Analysis of case-control studies of the efficacy of screening for cancer (how should we deal with tests done in persons with symptoms?). Am. J. Epidemiol. 1998;147:1099–1102
  20. Connor RJ, Boer R, Prorok PC, Weed DL. Investigation of design and bias issues in case-control studies of cancer screening using microsimulation. Am. J. Epidemiol. 2000;151:991–998
  21. Wingo PA, Ries LAG, Gioyino GA, et al.  Annual report to the nation on the status of cancer, 1973–1996, with a special section on Lung cancer and tobacco smoking. J. Natl. Cancer Inst. 1999;91:675–690
  22. Burns DM. Primary prevention, smoking, and smoking cessation. Cancer. 2000;89:2506–2509
  23. Sone S, Takashima S, Li F, et al.  Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998;351:1242–1245
  24. Hasson MA, Fagerstrom RM, Kahane DC, et al.  Design and evolution of the data management systems in the Prostate, Lung Colorectal and Ovarian (PLCO) cancer screening trial. Control Clin. Trials. 2000;21(Suppl.):329S–348S

PII: S0959-8049(02)00083-7

European Journal of Cancer
Volume 38, Issue 10 , Pages 1380-1387 , July 2002

Article Tools